Key facts
- It has raised $14.8M across 1 recorded rounds; the latest was Seed Round ($256K) in Nov 2023.
- Notable investors include Hatteras Venture Partners, Health Catalyst Capital Management, Homebrew Management, Knightsgate Ventures, Pisgah Fund — 6 tracked in total.
- Ilumivu has filed 4 Form Ds with the SEC since 2021, most recently Nov 2023 ($256K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Ilumivu
Funding rounds
1 roundsAbout Ilumivu
Developer of a patient-centered platform designed to capture rich, multimodal behavioral data streams through user engagement. The company's platform provides healthcare decision support applications using the psychology of behavior change, combined with real-time data from smartphones and wearables, enabling patients suffering from diabetes, sleep apnea, and hypertension to effectively measure outcomes and track the process of change.
- Sector
- Healthcare
- HQ
- Asheville, NC, United States
- Founded
- 2009
- Employees
- 11
- Website
- ilumivu.com/
- Ownership
- Privately Held (backing)
Ilumivu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ilumivu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ilumivu in its N-PORT filings yet. We sweep new filings monthly.